ISARIC Assembly 2021

Opening session – A Global Clinical Research Network for Global Health Security

12:00 – 12:15 GMT	Welcome	15’	Roberto Bruzzone, Chair
12:15 – 12:20 GMT	Keynote speaker	5’	Mike Ryan, Executive Director, WHO Health Emergencies Programme
12:20 – 12:45 GMT	The need for global clinical research capability – ISARIC as a foundation network	25’	Peter Horby, Executive Director

Session 2 – A Sustainable Clinical Surveillance and Analysis Network
Chairs: Yaseen Arabi and Armand Sprecher

12:50 – 12:55 GMT	Introduction	5’	Chairs
12:55 – 13:10 GMT	How the observational studies platform evolved in the context of COVID-19	15’	Alistair Nichol, ICC-CTN
13:10 – 13:25 GMT	Aggregating and analysing international data, partner analyses	15’	Felipe Reyes, LIVEN
13:25 – 13:40 GMT	Supporting research networks	15’	Waasila Jassat, NICD
13:40 – 13:45 GMT	Break
13:45 – 14:00 GMT	Integrating clinical research platforms into pandemic and epidemic intelligence	15’	Oliver Morgan, Director, Health Emergency Information and Risk Assessment, WHO Health Emergencies Programme
14:00 – 14:15 GMT	Future plans for outbreak research designs	15’	Srinivas Murthy, Board Member
14:15 – 14:30 GMT	Technical innovations and future plans	15’	Laura Merson, Head of Data
14:30 – 15:00 GMT	Panel discussion and Q&A	30’	Chairs
15:00 GMT	End of Day One

Session 3 – Strengthened Global Clinical Trials Architecture
Chairs: Gail Carson and Lina Moses

12:00 – 12:05 GMT	Introduction	5’	Gail Carson, Director of Network Development
12:05 – 12:45 GMT	ISARIC Regional Hubs: strengthening local clinical trials capacity	40’	Madiha Hashmi, SEARCH Muge Cevik, EDCTP SimpliciTB COVID19 Consortium & Janice Caoili, TDF Fernando Bozza, BRICNet John Amuasi, ALERRT
12:45 – 13:00 GMT	Building baseline data for improved clinical research, trials and best practice	15’	ISARIC Fellows – Joseph Bonney, Paa Kobina Forson, Moses Siaw-Frimpong
13:00 – 13:10 GMT 13:10 – 13:30 GMT	Keynote speaker Panel discussion	10′ 20′	Jeremy Farrar, Director of Wellcome Speakers, Muge Cevik, EDCTP SimpliciTB, Lina Moses, GOARN & Kenny Baillie, GenOMICC

Session 4 – Research Studies and Co-designed Clinical Development Plans
Chairs: Piero Olliaro and Adebola Olayinke

13:30 – 13:40 GMT	Introduction	10’	Piero Olliaro, Director of Science
13:40 – 14:00 GMT	Navigating the challenges of competing epidemics in a randomised controlled trial: a case study of bubonic plague	20’	Rindra Randremanana, IPM Mihaja Raberahona, CICM
14:00 – 14:15 GMT	An alternative approach to generating clinical evidence for novel therapeutics when traditional trial designs are not feasible: the use of an expanded access programme for monkeypox	15’	Emmanuel Nakouné, IPB
14:15 – 14:45 GMT	Co-designed clinical development plans: the West Africa Lassa fever Consortium	30’	Piero Olliaro, Director of Science Adebola Olayinke, NCDC
14:45 – 15:00 GMT	Summary and Q&A	15’	Piero Olliaro, Director of Science

Session 5 – Member Assembly (Closed session)

15:10 – 15:25 GMT	Recap and voting	15’	Peter Horby, Executive Director
15:25 – 15:30 GMT	Closing remarks	5’	Roberto Bruzzone, Chair
15:30	Member Assembly closed

ISARIC Zoom background (right-click with mouse and select “Save image to downloads“)